The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetic profile of once-daily ritonavir-boosted darunavir in HIV-1-infected subjects

被引：0
|
作者：
Garvey, L. [1 ]
Latch, N. [1 ]
Erlwein, O. [1 ]
Mohammed, P.
Mackie, N. [2 ]
Walsh, J. [2 ]
Scullard, G. [2 ]
McClure, M. [1 ]
Dickinson, L. [3 ]
Back, D. [3 ]
Winston, A. [1 ]
机构：
[1] Imperial Coll London, London, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
HIV MEDICINE | 2010年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [1] The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients
    Garvey, Lucy
    Latch, Ngaire
    Erlwein, Otto W.
    Mackie, Nicola E.
    Walsh, John
    Scullard, George
    McClure, Myra O.
    Dickinson, Laura
    Back, David
    Winston, Alan
    [J]. ANTIVIRAL THERAPY, 2010, 15 (02) : 213 - 218
  • [2] Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients
    Jablonowska, Elzbieta
    Pulik, Piotr
    Kalinowska, Anna
    Gasiorowski, Jacek
    Parczewski, Milosz
    Bociaga-Jasik, Monika
    Pulik, Lukasz
    Siwak, Ewa
    Wojcik, Kamila
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (12) : 2122 - 2129
  • [3] A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
    Spagnuolo, Vincenzo
    Galli, Laura
    Poli, Andrea
    Bigoloni, Alba
    Fumagalli, Luca
    Gianotti, Nicola
    Nozza, Silvia
    Ferrari, Davide
    Locatelli, Massimo
    Lazzarin, Adriano
    Castagna, Antonella
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 477 - 479
  • [4] Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women
    Crauwels, H. M.
    Kakuda, T. N.
    Ryan, B.
    Zorrilla, C.
    Osiyemi, O. O.
    Yasin, S.
    Brown, K.
    Verboven, P.
    Hillewaert, V.
    Baugh, B.
    [J]. HIV MEDICINE, 2016, 17 (09) : 643 - 652
  • [5] Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children
    van der Lee, Manon
    Verweel, Gwenda
    de Groot, Ronald
    Burger, David
    [J]. ANTIVIRAL THERAPY, 2006, 11 (04) : 439 - 445
  • [6] Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)
    Taiwo, Babafemi
    Zheng, Lu
    Gallien, Sebastien
    Matining, Roy M.
    Kuritzkes, Daniel R.
    Wilson, Cara C.
    Berzins, Baiba I.
    Acosta, Edward P.
    Bastow, Barbara
    Kim, Peter S.
    Eron, Joseph J., Jr.
    [J]. AIDS, 2011, 25 (17) : 2113 - 2122
  • [7] NON-INFERIORITY OF ONCE-DAILY COBICISTAT-BOOSTED DARUNAVIR VERSUS RITONAVIR-BOOSTED DARUNAVIR IN HIV-1-INFECTED ADULT PATIENTS: AN ADJUSTED COMPARATIVE ANALYSIS OF POOLED PHASE 3 DATA
    Van Sanden, S.
    Thilakarathne, P.
    Opsomer, M.
    Mrus, J.
    Vanveggel, S.
    Lathouwers, E.
    Adriaenssen, I
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A664 - A664
  • [8] Pharmacokinetic profile of maraviroc 150 mg dosed with darunavir/ritonavir once daily, with and without nucleoside analogues, in HIV-infected subjects
    Mora-Peris, B.
    Croucher, A.
    Else, L.
    Khoo, S.
    Vera, J.
    Back, D.
    Winston, A.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 56 - 57
  • [9] Pharmacokinetics of once-daily dolute-gravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study
    Spinner, Christoph D.
    Kuemmerle, Tim
    Krznaric, Ivanka
    Degen, Olaf
    Schwerdtfeger, Christiane
    Zink, Alexander
    Wolf, Eva
    Klinker, Hartwig H. F.
    Boesecke, Christoph
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (09) : 2679 - 2681
  • [10] Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
    Conradie, F.
    Zorrilla, C.
    Josipovic, D.
    Botes, M.
    Osiyemi, O.
    Vandeloise, E.
    Eley, T.
    Child, M.
    Bertz, R.
    Hu, W.
    Wirtz, V.
    McGrath, D.
    [J]. HIV MEDICINE, 2011, 12 (09) : 570 - 579
12345